Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDNA | Common Stock | Options Exercise | $610 | +500 | +0.83% | $1.22* | 61.1K | Oct 11, 2021 | Direct | F1 |
transaction | CDNA | Common Stock | Sale | -$31.3K | -500 | -0.82% | $62.50 | 60.6K | Oct 11, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDNA | Stock Option (right to buy) | Options Exercise | $0 | -500 | -3.33% | $0.00 | 14.5K | Oct 11, 2021 | Common Stock | 500 | $1.22 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.5 to $62.505, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
F3 | 1/12th of the shares subject to the option vested on August 13, 2017 and the remaining shares subject to the option vested monthly thereafter through July 13, 2018. |